Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 22, 2023

Seroreactivity Against Lytic, Latent, and Possible Cross-Reactive EBV Antigens Appears on Average 10 Years Before MS-Induced Preclinical Neuroaxonal Damage

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage
J. Neurol. Neurosurg. Psychiatr. 2023 Oct 06;[EPub Ahead of Print], D Jons, V Grut, T Bergström, H Zetterberg, M Biström, M Gunnarsson, M Vrethem, N Brenner, J Butt, K Blennow, S Nilsson, I Kockum, T Olsson, T Waterboer, P Sundström, O Andersen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading